Atlas Trials

A Study: Pure CBD as Single-agent for Solid Tumor.

Clinical trial NCT02255292 · UNKNOWN

Trial details

NCT number
NCT02255292
Sponsor
Hadassah Medical Organization
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Solid Tumor
Start date
2014-11-01
Primary completion
2015-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.